Health committee  The very example of Canada would provide sufficient evidence to conclude that there's not much link. As I mentioned, we pay the third-highest prices for patented medicines in the world, and yet the ratio of our R and D to sales pales in comparison to the countries we compare ours

Health committee  The OECD...

Health committee  Yes, we're lower than where we started in 1987 when we committed to strengthening patent protection for pharmaceuticals and established the PMPRB to protect consumers from excessively priced patented drugs. We were at about 5% at the time. The industry did meet its 10% commitme

Health committee  Mr. Chair, members of the committee, good morning. Thank you for the invitation to appear before you today. Before I move on to the questions, I want to take a few minutes to explain where the Patented Medicine Prices Review Board, or the PMPRB, stands in the Canadian health car